. . . . . . . "[Three of these markers - 1p/19q deletions, MGMT methylation status, and mutations in the IDH1 gene - are so potent that a new brain tumor subtype, the 'triple negative' glioma (1p/19q intact, MGMT unmethylated, IDH1 non-mutated) has entered common parlance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:13:34+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .